These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1305924)

  • 1. [Evaluation of contents of A and B group substances in biological preparations].
    Banach W
    Med Dosw Mikrobiol; 1992; 44(3-4):201-5. PubMed ID: 1305924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biologically active substances, other than antibodies, in preparations of normal human immunoglobulin. I. Serum proteins, blood group substances and hemoprotein compounds].
    Banach W
    Med Dosw Mikrobiol; 1986; 38(4):241-8. PubMed ID: 3561098
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of blood group specific substances A and B and human chorionic gonadotropin in human immunoglobulins and albumins.
    Guencheva G; Manolova L
    Dev Biol Stand; 1979; 44():63-7. PubMed ID: 544301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Content of IgE in preparations of human immunoglobulin for intravenous use (IVIG)].
    Bucholc B; Banach W
    Med Dosw Mikrobiol; 1993; 45(4):517-21. PubMed ID: 8189833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of antibacterial and antitoxic activity of normal human immunoglobulin for intravenous use (IVIG)].
    Bucholc B; Banach W; Wysokińska T; Cieślik A; Chodorowska M
    Med Dosw Mikrobiol; 1996; 48(1-2):87-94. PubMed ID: 8926773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biologically active substances, other than antibodies, in preparations of normal human immunoglobulin. II. Placental proteins].
    Banach W
    Med Dosw Mikrobiol; 1986; 38(4):249-56. PubMed ID: 3561099
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of prekallikrein activator (PKA) activity in plasma-derived preparations].
    Miks B; Aleksandrowicz J; Kawiak J
    Med Dosw Mikrobiol; 1990; 42(3-4):171-7. PubMed ID: 2128105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mechanism of blood group (ABO)-expression.
    Yoshida A
    Acta Biol Med Ger; 1981; 40(7-8):927-41. PubMed ID: 6800172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the degree of degradation of human placental immunoglobulin preparations].
    Aleksandrowicz J; Zakrzewska A
    Med Dosw Mikrobiol; 1983; 35(3-4):269-75. PubMed ID: 6374336
    [No Abstract]   [Full Text] [Related]  

  • 11. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products.
    Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
    Vox Sang; 2009 Aug; 97(2):160-8. PubMed ID: 19402856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma kallikrein and prekallikrein activator (PKA) activities in various preparations of human immunoglobulins and albumins].
    Kawiak J; Aleksandrowicz J; Kawalec M; Drozdz M
    Med Dosw Mikrobiol; 1987; 39(3):203-7. PubMed ID: 3499549
    [No Abstract]   [Full Text] [Related]  

  • 13. Amino-acid substitution in the disordered loop of blood group B-glycosyltransferase enzyme causes weak B phenotype.
    Yazer MH; Denomme GA; Rose NL; Palcic MM
    Transfusion; 2005 Jul; 45(7):1178-82. PubMed ID: 15987364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
    Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method.
    Thorpe SJ; Fox BJ; Dolman CD; Thorpe R
    Biologicals; 2005 Jun; 33(2):111-6. PubMed ID: 15905100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the content of blood group substances A and B in immunoglobulins prepared from placental and donor sera].
    Gencheva GP; Minakova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):115-9. PubMed ID: 919912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-vaccination reactions and complications of pertussis, diphtheria and tetanus vaccines].
    Vuković B; Seguljev Z; Nikolić V; Nad E
    Med Pregl; 1991; 44(11-12):513-6. PubMed ID: 1821455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved standardization in the quantitative estimation of soluble immune complexes making use of an international reference preparation. Results of a collaborative multicentre study.
    Nydegger UE; Svehag SE
    Clin Exp Immunol; 1984 Nov; 58(2):502-9. PubMed ID: 6499284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of immunoglobulin M-enriched intravenous immunoglobulins against bacterial infections and on the neutralization of bacterial toxins].
    Dichtelmüller H; Stephan W
    Arzneimittelforschung; 1987 Nov; 37(11):1273-6. PubMed ID: 3440036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral activity of commercial immunoglobulin preparations].
    Litwińska B; Bucholc B; Sadowski W; Kańtoch M
    Med Dosw Mikrobiol; 1990; 42(1-2):89-94. PubMed ID: 1964995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.